- Home
- ECOR vs AKYA Comparison
ECOR vs AKYA Comparison
Compare ECOR & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- AKYA
- Stock Information
- Founded
- ECOR 2005
- AKYA 2015
- Country
- ECOR United States
- AKYA United States
- Employees
- ECOR N/A
- AKYA N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- AKYA Medical Specialities
- Sector
- ECOR Health Care
- AKYA Industrials
- Exchange
- ECOR Nasdaq
- AKYA Nasdaq
- Market Cap
- ECOR 50.1M
- AKYA 56.1M
- IPO Year
- ECOR 2018
- AKYA 2021
- Fundamental
- Price
- ECOR $5.22
- AKYA $1.26
- Analyst Decision
- ECOR Strong Buy
- AKYA Hold
- Analyst Count
- ECOR 2
- AKYA 7
- Target Price
- ECOR $25.50
- AKYA $2.51
- AVG Volume (30 Days)
- ECOR 84.4K
- AKYA 263.7K
- Earning Date
- ECOR 08-06-2025
- AKYA 08-04-2025
- Dividend Yield
- ECOR N/A
- AKYA N/A
- EPS Growth
- ECOR N/A
- AKYA N/A
- EPS
- ECOR N/A
- AKYA N/A
- Revenue
- ECOR $26,458,000.00
- AKYA $79,961,000.00
- Revenue This Year
- ECOR $23.21
- AKYA $7.26
- Revenue Next Year
- ECOR $44.10
- AKYA $11.44
- P/E Ratio
- ECOR N/A
- AKYA N/A
- Revenue Growth
- ECOR 41.54
- AKYA N/A
- 52 Week Low
- ECOR $4.47
- AKYA $0.93
- 52 Week High
- ECOR $19.49
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- ECOR 45.50
- AKYA 52.71
- Support Level
- ECOR $5.05
- AKYA $1.21
- Resistance Level
- ECOR $5.81
- AKYA $1.35
- Average True Range (ATR)
- ECOR 0.32
- AKYA 0.08
- MACD
- ECOR 0.05
- AKYA 0.01
- Stochastic Oscillator
- ECOR 39.84
- AKYA 60.71
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.